Adani and executives face expanded U.S. indictment alleging a $250 million bribery scheme to Indian officials for solar power contracts, leading to significant financial and political repercussions.
U.S. tightens sanctions on Gazprombank, Russia's third-largest bank, to limit its ability to finance military operations in Ukraine.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Adani and executives face expanded U.S. indictment alleging a $250 million bribery scheme to Indian officials for solar power contracts, leading to significant financial and political repercussions.
U.S. tightens sanctions on Gazprombank, Russia's third-largest bank, to limit its ability to finance military operations in Ukraine.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.